A low A1c generally means your average blood sugar over the past two to three months has been on the lower end, but it doesn’t always tell the full story. A normal A1c falls below 5.7%, so readings in the low-to-mid 5% range are typically healthy. When A1c drops well below that, particularly under 4.0%, it can signal an underlying medical condition, a medication side effect, or a lab result that isn’t reflecting your true blood sugar levels.
How the A1c Test Works
The A1c test measures how much glucose has attached to your red blood cells’ hemoglobin over their roughly 120-day lifespan. Because it captures a rolling average rather than a single moment in time, it’s resistant to the daily ups and downs of blood sugar. That stability is what makes it so useful for tracking diabetes and prediabetes. But it also means that anything affecting your red blood cells or hemoglobin can throw the number off, making your blood sugar look lower (or higher) than it actually is.
What Counts as “Low”
There’s no single cutoff that defines a dangerously low A1c, but context matters. For someone without diabetes, an A1c between about 4.0% and 5.6% is considered normal. Readings below 4.0% are uncommon and worth investigating. For someone with diabetes, an A1c that drops significantly below their target range could mean they’re experiencing frequent episodes of low blood sugar, which carries its own risks.
When a Low A1c Is Genuinely Good News
If you’re otherwise healthy, eating well, and not on any medication that lowers blood sugar, a low-normal A1c (say, in the 4.5% to 5.2% range) simply reflects good glucose control. It means your body is processing sugar efficiently. There’s nothing to worry about in this scenario, and no action needed.
Medical Conditions That Lower A1c Artificially
A surprisingly low A1c doesn’t always mean your blood sugar is actually low. Several conditions shorten the lifespan of red blood cells, which means hemoglobin has less time to accumulate glucose. The result is a number that looks reassuringly normal even when blood sugar is elevated.
Hemolytic anemia is the classic example. When red blood cells break down faster than usual, they don’t circulate long enough to reflect your true average glucose. The A1c reads artificially low, potentially masking diabetes or prediabetes that would otherwise be caught.
Liver cirrhosis produces a similar effect. The enlarged spleen that often accompanies cirrhosis destroys red blood cells prematurely, and A1c levels in cirrhotic patients frequently fall within the normal 4% to 6% range even when blood sugar is elevated. This makes the test unreliable for detecting diabetes in people with advanced liver disease.
Advanced kidney disease also shortens red blood cell survival. Patients with more advanced kidney disease tend to have relatively low A1c readings even when their glucose levels are comparable to patients with milder disease. This can create a false sense of security about blood sugar control.
Significant blood loss, recent blood transfusions, and certain inherited hemoglobin variants can all skew A1c results downward for similar reasons. In any of these situations, the test is measuring red blood cell turnover as much as it’s measuring glucose.
Medications and Supplements That Push A1c Down
For people with diabetes, certain medications are more likely to drive A1c below target. Insulin and a class of oral medications called sulfonylureas carry the highest risk of hypoglycemia (low blood sugar episodes). One large study found that sulfonylurea use was associated with nearly three times the risk of hypoglycemia compared to metformin. If your A1c has dropped lower than expected and you take either of these, frequent low blood sugar episodes could be pulling your average down.
High-dose vitamin C supplements have also been shown to modestly reduce A1c readings. A systematic review of clinical trials found that vitamin C supplementation lowered A1c by about 0.5 percentage points in people with type 2 diabetes. Whether this reflects a true improvement in blood sugar or an interference with the lab test itself remains debated, but it’s worth mentioning to your doctor if you supplement heavily.
Why Very Low A1c Can Be a Warning Sign
A large study of U.S. adults without diabetes found that an A1c below 4.0% was associated with nearly three times the risk of death from any cause compared to people with an A1c between 5.0% and 5.4%. That elevated risk held up even after researchers accounted for age, lifestyle, cardiovascular health, red blood cell characteristics, iron levels, and liver function.
This doesn’t mean a low A1c directly causes harm. Rather, very low readings often point to an underlying condition, whether it’s chronic anemia, liver disease, malnutrition, or another process that shortens red blood cell lifespan or disrupts normal metabolism. The low number is a signal, not the problem itself.
Recognizing Low Blood Sugar Symptoms
If a low A1c reflects genuinely low blood sugar rather than a testing artifact, you may already be experiencing symptoms. Blood sugar below 70 mg/dL can cause a fast heartbeat, shaking, sweating, anxiety, dizziness, and sudden hunger. Below 54 mg/dL, symptoms become more serious: weakness, difficulty walking, blurred vision, confusion, and in severe cases, seizures. People with diabetes who are tightly managed are most at risk, but reactive hypoglycemia can occur in non-diabetics too, particularly after high-carbohydrate meals.
Low A1c During Pregnancy
A1c naturally drops during pregnancy. In non-diabetic pregnant women, normal ranges shift by trimester: roughly 4.0% to 5.5% in the first trimester, 3.9% to 5.3% in the second, and 4.1% to 5.7% in the third. The dip during the second trimester is partly driven by increased blood volume diluting hemoglobin and the overall decrease in fasting blood sugar that occurs mid-pregnancy. A low A1c during pregnancy is usually expected, not concerning, though it does make the test less useful for catching gestational diabetes.
Alternative Tests When A1c Is Unreliable
When a medical condition makes A1c unreliable, doctors often turn to a fructosamine test. Instead of measuring glucose attached to hemoglobin, fructosamine measures glucose attached to proteins in the blood, primarily albumin. Because these proteins turn over every two to three weeks rather than every three to four months, the test gives a shorter-term snapshot that isn’t affected by red blood cell lifespan. It’s particularly useful for people with hemolytic anemia, kidney disease, hemoglobin variants, or conditions where blood sugar is changing rapidly, like new insulin therapy or steroid treatment.
Continuous glucose monitoring is another option that bypasses A1c entirely. It tracks blood sugar in real time, giving a direct picture of glucose patterns including how much time you spend in, above, or below your target range. Current guidelines suggest that spending more than 70% of the time within target range (with less than 4% of time spent below range) is a reasonable goal for most adults with diabetes.